| ATRASENTAN 
| ATRASENTAN | CARDIOVASCULAR ENDOTHELIN RECEPTOR ANTAGONIST (KI = 0.034 NANOMOLAR) REDUCE PROTEINURIA IN ADULTS WITH PRIMARY IMMUNOGLOBULIN A NEPHROPATHY (IGAN) AT RISK OF RAPID DISEASE PROGRESSION | ORAL | Tmax 0.5 HOUR VD 1180 LITER PPB 99 PERCENT Cl 19 LITER / HOUR HT 32.5 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | ENDOTHELIN RECEPTOR TYPE A ETA | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com VigiAccess SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |